Search
Displaying 481–490 of 613 for “retinal diseases”
-
Research News
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
-
Philadelphia Vision Connection – Spring, 2025
- Jun 18, 2025
- 5:00 p.m. (EDT)
- 840 Walnut St., Philadelphia, PA 19107
Community EventJoin us to connect, learn, and network!
-
News
The company is planning a Phase 2/3 clinical trial for the therapy in late 2025.
-
Leber Congenital Amaurosis Research Advances
Research NewsRecent developments in research on Leber congenital amaurosis
-
Mental Health Advisory Council
The Foundation Fighting Blindness mental health initiative is guided by a mental health advisory council (MHAC) which includes five expert therapists (four of whom are blind or have low vision), a retinal specialist who has treated patients facing severe depression and anxiety, and a Foundation Board Member affected by vision loss who organized a local mental health support group.
-
Eye on the Cure Podcast | Episode 78: Dr. Sheldon Rowan
Eye on the CureDr. Rowan talks about the impact of the glycemic index, microbiome, and diet on the development of age-related macular degeneration and optimization of overall retinal health.
-
Share Your Vision: Heather Edwards
Beacon StoriesHeather Edwards has turned her personal journey with cone-rod dystrophy into a mission to support others facing similar challenges. Despite facing difficulties during her youth, Heather now uses her experiences to advocate for awareness and support for blinding diseases, emphasizing that blindness is a spectrum and each person’s experience is uniquely valuable.
-
Research News
The Phase 3 trial is expected to begin in Q1 2025
-
AREDS Formula Reduces Risk of Visual Acuity Loss for People with Geographic Atrophy
Research NewsPreviously, the formula was thought to only reduce risk of early age-related macular degeneration advancing to late-stage disease
-
Eye on the Cure Podcast | Episode 69: Dr. Francois Paquet-Durand
Eye on the CureFrancois Paquet-Durand, PhD, a professor from the University of Tübingen and co-founder of the company Mireca, talks to host Ben Shaberman about the long journey of an emerging, Foundation-funded drug for the treatment of certain forms of retinitis pigmentosa. The episode highlights the challenges that scientists often encounter when developing a drug for a retinal disease, and the persistence and tenacity that are required to keep it moving forward.
.png)
